252 related articles for article (PubMed ID: 10069947)
1. Poliomyelitis in intraspinally inoculated poliovirus receptor transgenic mice.
Deatly AM; Coleman JW; McMullen G; McAuliffe JM; Jayarama V; Cupo A; Crowley JC; McWilliams T; Taffs RE
Virology; 1999 Mar; 255(2):221-7. PubMed ID: 10069947
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mouse lines transgenic with the human poliovirus receptor gene.
Deatly AM; Taffs RE; McAuliffe JM; Nawoschik SP; Coleman JW; McMullen G; Weeks-Levy C; Johnson AJ; Racaniello VR
Microb Pathog; 1998 Jul; 25(1):43-54. PubMed ID: 9705248
[TBL] [Abstract][Full Text] [Related]
3. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.
Yang WX; Terasaki T; Shiroki K; Ohka S; Aoki J; Tanabe S; Nomura T; Terada E; Sugiyama Y; Nomoto A
Virology; 1997 Mar; 229(2):421-8. PubMed ID: 9126254
[TBL] [Abstract][Full Text] [Related]
4. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
[TBL] [Abstract][Full Text] [Related]
5. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
Nagata N; Iwasaki T; Ami Y; Sato Y; Hatano I; Harashima A; Suzaki Y; Yoshii T; Hashikawa T; Sata T; Horiuchi Y; Koike S; Kurata T; Nomoto A
Virology; 2004 Mar; 321(1):87-100. PubMed ID: 15033568
[TBL] [Abstract][Full Text] [Related]
6. Poliovirus-sensitive transgenic mice as a new animal model.
Koike S; Horie H; Sato Y; Ise I; Taya C; Nomura T; Yoshioka I; Yonekawa H; Nomoto A
Dev Biol Stand; 1993; 78():101-7. PubMed ID: 8388819
[TBL] [Abstract][Full Text] [Related]
7. Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.
Levenbook I; Nomura T
Lab Anim Sci; 1997 Apr; 47(2):118-20. PubMed ID: 9150487
[TBL] [Abstract][Full Text] [Related]
8. [The observation on infection of trasgenic mice (PVR Tg21) with polioviruses type 3].
Guo R; Chen S; Luo Q; Wang Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):70-5. PubMed ID: 11367738
[TBL] [Abstract][Full Text] [Related]
9. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
Racaniello VR; Ren R; Bouchard M
Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis of poliomyelitis: what we don't know.
Nathanson N
Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
[TBL] [Abstract][Full Text] [Related]
11. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H
J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246
[TBL] [Abstract][Full Text] [Related]
12. Retrograde transport of intact poliovirus through the axon via the fast transport system.
Ohka S; Yang WX; Terada E; Iwasaki K; Nomoto A
Virology; 1998 Oct; 250(1):67-75. PubMed ID: 9770421
[TBL] [Abstract][Full Text] [Related]
13. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
14. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.
Abe S; Ota Y; Doi Y; Nomoto A; Nomura T; Chumakov KM; Hashizume S
Virology; 1995 Jun; 210(1):160-6. PubMed ID: 7793068
[TBL] [Abstract][Full Text] [Related]
15. One hundred years of poliovirus pathogenesis.
Racaniello VR
Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
[TBL] [Abstract][Full Text] [Related]
16. [Mouse neurovirulence of antigenic chimeras (type I/II) of polioviruses].
Dai C
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):34-8. PubMed ID: 7686824
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of poliovirus neurovirulence.
Ohka S; Nomoto A
Dev Biol (Basel); 2001; 105():51-8. PubMed ID: 11763337
[TBL] [Abstract][Full Text] [Related]
18. Poliovirus neurovirulence and attenuation, a conceptual framework.
John TJ
Dev Biol Stand; 1993; 78():117-9. PubMed ID: 8388822
[No Abstract] [Full Text] [Related]
19. Random selection: a model for poliovirus infection of the central nervous system.
Georgescu MM; Balanant J; Ozden S; Crainic R
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1819-28. PubMed ID: 9266975
[TBL] [Abstract][Full Text] [Related]
20. A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine.
Dragunsky E; Taffs R; Chernokhvostova Y; Nomura T; Hioki K; Gardner D; Norwood L; Levenbook I
Biologicals; 1996 Jun; 24(2):77-86. PubMed ID: 8889053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
